Agreement signedAgreed 4 Mar 2025
Jazz Pharmaceuticals Public Limited Company /
Chimerix, Inc.
Jazz Pharmaceuticals Public Limited Company agrees to buy Chimerix, Inc.
01 / BuyerJazz Pharmaceuticals Public Limited Company
02 / TargetChimerix, Inc.
Source-verifiedWhat happened
Jazz Pharmaceuticals Public Limited Company agreed to acquire Chimerix, Inc. for $8.55 per share, according to a filing dated April 21, 2025.
The source
Everything on this page comes from the source below.
01
Source · Original source
Jazz Pharmaceuticals Public Limited Company agrees to buy Chimerix, Inc.
This document is the source for the companies, stage, figure and people on this page.
Source-verifiedTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
Source-verifiedAnnounced
The source this page is built from.
Source-verified
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request an inviteAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly